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along with certain genetic factors (genetic polymorphisms) 
that adversely affect the levels of such variables, for 
example, angiotensin converting enzyme (ACE) gene 
polymorphism (insertion/deletion [I/D]) or ACE (I/D) 
and ApolipoproteinE gene (ApoE) polymorphisms.[5] 
Throughout the Asia-Paciﬁ  c region, there are differences 
in obesity prevalence as well as in body fat distribution[6] 
In Asian populations, morbidity and mortality from 
cardiovascular diseases (CVD) is occurring also in people 
with lower body mass index (BMI) and smaller waist 
circumference.[7,8] Thus, they tend to accumulate intra-
abdominal visceral fat without developing generalized 
obesity.[1,7-9] South Asians have a more centralized 
INTRODUCTION
The prevalence of coronary heart disease (CHD) is known 
to be very high among Indians, both in India and abroad. 
Moreover, among Indians, CHD occurs at least a decade 
or 2 earlier compared with Europeans.[1,2] The reason for 
the increased susceptibility of Indians to CHD is yet to 
be completely understood. However, several studies have 
hinted that the clustering of risk variables (mechanism of 
which is still unknown) of metabolic syndrome (MS) could 
be responsible for the increasing incidence of CHD among 
Indians. This includes central obesity, hypertriglyceridemia, 
less levels of high-density lipoprotein cholesterol, high 
blood pressure, and high levels of fasting blood glucose,[1-4] 
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ABSTRACT
Background: Several studies hinted about the clustering of risk variables of the metabolic syndrome (MS) 
and suggested that the underlying genetic polymorphisms could be responsible for the increasing incidence of 
coronary heart disease (CHD) in people of Indian origin. Therefore, identiﬁ  cation of the components of the MS 
along with the genetic factors could be one of the aspects to make an attempt to prevent the increasing incidence 
of CHD. Materials and Methods: Principal component factor analysis (PCFA) was undertaken to identify the 
components or factors of the MS among the adult (≥30 years) Asian Indians living in and around Calcutta, India. 
The study comprised 350 adult Asian Indians. Anthropometric measurements were taken, and lipid proﬁ  les, 
blood pressure and fasting blood glucose were measured for each participant. Two genetic polymorphisms, 
namely, angiotensin converting enzyme (ACE) gene polymorphism (insertion/deletion [I/D]) or ACE (I/D) 
and apolipoproteinE (Hha I) were also studied. Results: PCFA revealed 3 factors that cumulatively explained 
65.39% of the observed variance of the MS by measured variables. The 3 factors identiﬁ  ed were lipids and 
lipoprotein (Factor 1), centripetal fat and blood pressure (Factor 2), and ACE (I/D) polymorphism with blood 
pressure (Factor 3). Moreover, the ﬁ  rst 2 factors, that is, lipids, lipoprotein, centripetal fat, and blood pressures 
cumulatively explained ~46% (45.94%) of the observed variance of MS in this population. Conclusions: 
Since more than 1 factor was identiﬁ  ed for the MS phenotype, more than 1 physiogenetic mechanism could be 
accounted for MS in the Asian Indian population. 
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distribution of body fat and markedly higher mean waist–
hip ratio for a given level of BMI compared with Europeans 
and Americans.[5-9] The MS, which can be deﬁ  ned as the 
constellation of CVD risk factors, is one of the growing 
public health burdens in the Asia-Paciﬁ  c region, although 
people of this region are no more overweight than 
Europeans and Americans.[6,9] 
Several statistical techniques could be applied to identify 
the components of the MS. Principal component factor 
analysis (PCFA) is one such approach that groups 
quantitatively measured variables into clusters known 
as factors, on the basis of the correlation between 
variables.[10] PCFA was used to identify the domains of the 
risk variables of the MS. For example, if there is a single 
underlying cause for the clustering of the risk variables 
of the MS, then factor analysis should produce only 1 
major factor or component. Therefore, identiﬁ  cation of 
component(s) of the MS (considered to be the leading 
cause of CHD) is most essential for the etiology of CHD[7] 
However, a very few studies have so far been undertaken 
to identify the components of the MS in Asian Indian 
population[7-9,11-15] These studies suggested that there existed 
no single or central etiological factor for the clustering of 
MS phenotypes.[7,8] Therefore, it seems reasonable to argue 
that several underlying abnormalities do exist that might 
have relatively greater genetic basis.[7,8] 
However, to the best of the authors’ knowledge, no study 
has been undertaken on Asian Indians incorporating the 
genetic polymorphism(s), lipids, blood glucose, blood 
pressure, and body fat patterns simultaneously to identify 
the components of MS in this ethnic group. Keeping this 
view in mind, the present investigation is an attempt to ﬁ  nd 
out the physiogenetic factors responsible for the observed 
variation of MS in the Asian Indian population living in 
the eastern part of India. 
MATERIALS AND METHODS
Study population
The present community-based cross-sectional study 
comprised adult (≥30 years) Asian Indians living in and 
around Calcutta, India. A total of 350 (male = 184 and 
female = 166) individuals participated in the study. Pregnant 
women, women undergoing hormone therapy, as well as 
individuals with known illnesses, such as ischemic heart 
disease, type 2 diabetes mellitus, and hypertension were 
not included in the study. Prior to participation, public 
advertisement was given about the study with the help 
of the local ofﬁ  cials. Individuals who responded to the 
advertisement were selected randomly. It is noteworthy that 
only unrelated adults from a household were included as 
participants to avoid the effects of intra-household clusters 
of CVD risk factors. The Institutional Ethics Committee 
(IEC) of the “Human Genetic Engineering Research 
Center” (HGERC), Calcutta, India, has approved the study. 
Written consent from the participants was also obtained 
prior to the actual commencement of the study. 
Anthropometric measurements
Anthropometric measurements, namely, height, weight, 
waist circumference, and subcutaneous skinfold were 
obtained using standard techniques.[16] Height and weight 
(in light clothing) were measured to the nearest 0.1 cm 
and 0.5 kg, respectively. Waist circumference (WC) was 
measured to the nearest 0.1 cm using an inelastic tape. The 
minimum WC was measured at the level of natural waist, 
which was the narrowest part of the torso. Subcutaneous 
skinfolds at biceps, triceps, suprailiac and subscapular 
sides were measured and the sum of the 4 skinfolds was 
computed subsequently. 
Blood pressure
Left arm systolic and diastolic blood pressure measurements 
were taken twice using sphygmomanometer and stethoscope 
and were averaged for analyses. A third measurement 
was taken only when the difference between the 2 
measurements was >5 mmHg. Previous medical records 
for blood pressure were also taken into consideration. 
Metabolic proﬁ  les
A fasting blood sample (~7 mL) was collected from each 
subject for determining the metabolic proﬁ  les. All the 
subjects maintained an overnight fast of >12 h prior to 
blood collection. Estimation of total cholesterol (TC), 
triglycerides (TG), high-density lipoprotein (HDL), and 
fasting blood glucose was carried out on separated serum 
by means of a semi-auto analyzer. All biochemical analyses 
were estimated in mg/dL (mg%) unit.
Genotyping
Two genetic polymorphisms, namely, ACE (I/D) and ApoE 
(Hha I) polymorphisms were studied in 138 participants. 
To study ACE (I/D) and ApoE (Hha I) polymorphisms, 
DNA samples of participants belonging to the highest 
(90th) and lowest (10th) percentiles of blood pressure 
centiles (percentiles) and/or lipids were considered. The 
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Table 1: Distribution of study population by age group 
and sex
Age group (years) Male Female
30–39 20 39
40–49 47 48
50–59 63 43
≥60 57 36
Table 2: Descriptive statistics of study population 
(n = 350)
Variables Mean SD 
Waist circumference (cm) 89.38 9.87
Sum of four skinfolds (mm) 97.09 26.58
Total cholesterol (mg%) 202.55 25.76
Triglyceride (mg%) 141.95 25.30
High-density lipoprotein (mg%) 44.35 4.72
Fasting blood glucose (mg%) 90.98 20.73
Systolic blood pressure (mmHg) 134.98 24.31
Diastolic blood pressure (mmHg) 82.82 11.01
detailed procedures of genotyping have been mentioned 
elsewhere.[17,18] 
Statistical analyses 
Descriptive statistics, such as mean and standard deviation 
(SD), of all the variables were calculated. Frequencies 
(%) of different alleles of ACE (I/D) and ApoE (HhaI) 
polymorphisms were also calculated. Factor analysis was 
undertaken to group quantitatively measured variables 
into clusters known as factors. It was done in 3 steps: 
computation of a correlation matrix for all variables 
included; factor extraction; and orthogonal rotation 
to make factors readily interpretable. The factors were 
extracted by PCFA in which the linear combinations of the 
variables were formed with the ﬁ  rst component accounting 
for the largest amount of variance in the sample. Varimax 
rotation, an orthogonal rotation in which the factors are 
assumed to act independently (maximum likelihood), was 
used in the study. The components were all uncorrelated. 
Variables with a factor loading of at least 0.3 have generally 
been considered for interpretation, although it is suggested 
that only loading ≥0.4, which therefore shares at least 
15% of the variance with a factor, should be used in the 
interpretation.[19] A factor loading of ≥0.4 was used to 
interpret the factors in the study. Previous studies have also 
used a factor loading of ≥0.4 to interpret the ﬁ  nal rotated 
factor pattern.[7,8,19-24] 
All statistical analyses were performed using SPSS (PC+ 
version 10). A P value of < 0.05 (two-tailed) was considered 
as statistically signiﬁ  cant.
RESULTS
The distribution of 184 males and 166 females by age 
groups and sex is presented in Table 1. It was observed 
that the participants were distributed more or less equally 
across the age groups and sex. 
The mean and standard deviation (SD) of anthropometric, 
lipids proﬁ  le, blood glucose, and blood pressure measures 
are presented in Table 2. The mean ± SD WC in the study 
population was 89.38 ± 9.87. The mean (SD) triglyceride 
in the study was 141.95 (25.30). When the known South 
Asians’ speciﬁ  c cutoffs were taken into consideration, the 
prevalence of MS in the study was 31.4%. 
The frequency of ACE (I/D) and ApoE (Hha I) gene 
polymorphisms is presented in Table 3. The frequency (%) 
of Insertion/Insertion (I/I) polymorphism for ACE gene 
was found to be the highest (37%) in the study. On the 
other hand, epsillion 3/ epsillion 3 for ApoE gene (Hha 
I) was the most frequent (60.9%) in the study population.
The factor-loading pattern of the 3 factors (components) 
identiﬁ  ed in the study is presented in Table 4. Only variables 
with loading ≥0.4 were considered for interpretation. The 
loading of individual risk variable varied from 0.413 to 0.915. 
The factor 1 (lipids, 25.53%); factor 2 (centripetal fat with 
blood pressure, 20.41%) and factor 3 (ACE gene along with 
blood pressure, 19.44%) cumulatively explained 65.39% 
of the total variation of MS in the study [Figure 1]. Most 
importantly, the ﬁ  rst two factors (lipids, centripetal fat along 
with blood pressure) cumulatively explained ~46% (45.94%) 
of the total variation of MS in the study population. 
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Figure 1: Clustering patterns of cardiometabolic risk variables in the 
study
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Table 3: Frequency of ACE and ApoE genotypes 
(n = 138)
Gene Polymorphic type n (%)
ACE Insertion/Insertion (I/I) 51 (37.0)
Insertion/Deletion (I/D) 47 (34.0)
Deletion/Deletion (D/D) 40 (29.0)
ApoE epsillion 2/ epsillion 3 23 (16.7)
epsillion 2/ epsillion 4 09 (6.5)
epsillion 3/ epsillion 3 84 (60.9)
epsillion 3/ epsillion 4 18 (13.0)
epsillion 4/ epsillion 4 04 (2.9)
ACE, angiotensin converting enzyme; ApoE, apolipoproteinE.
Table 4: Factor loading pattern of cardiometabolic risk 
factors
 Factors
Variables Factor 1 Factor 2 Factor 3
Waist circumference 0.196 0.868* 0.207
Sum of 4 skinfolds 0.108 0.915a 0.060
Total cholesterol 0.824* −0.069 0.002
Triglyceride 0.898* 0.251 0.090
High-density lipoprotein −0.867* −0.233 0.051
Fasting blood glucose 0.314 0.018 0.197
Systolic blood pressure −0.114 0.281 0.866*
Diastolic blood pressure −0.028 0.413* 0.808*
ACE gene polymorphism 0.280 −0.283 0.588a
ApoE gene polymorphism 0.275 0.000 0.316
Variance explained 25.53(%) 20.41 19.44
Cumulative variance 25.53(%) 45.94 65.39
ACE, angiotensin converting enzyme; ApoE, apolipoproteinE. a Loading with 
absolute value ≥ 0.4.
DISCUSSION
The association of central obesity, glucose intolerance, 
hypertension, dyslipidemia, and hyperinsulinemia known 
as MS, has been observed in a number of ethnic groups 
worldwide. Studies across populations demonstrate that MS 
plays a pivotal role in the occurrence of CVD, including 
CHD. Therefore, identiﬁ  cation of the components of 
the MS, including the genetic factors would be helpful in 
understanding the etiology of CHD. A very few studies 
have so far been undertaken to identify the underlying 
factors of MS in the Asian Indian population.[7-9,11-15] 
However, virtually no study has been undertaken on Asian 
Indians incorporating the genetic polymorphism(s), lipids, 
blood glucose, blood pressure, and body fat patterns 
simultaneously to identify the components of MS in 
this ethnic group. The present investigation was aimed 
at identifying the physiogenetic factors responsible for the 
observed variation of MS in Asian Indian population living 
in the eastern part of India. 
PCFA had identiﬁ  ed 3 factors with 65.39% that explained 
variance of the MS among the adult Asian Indians of 
Calcutta. Neither of the variables loaded on all the 3 
components. These 3 factors could be identiﬁ  ed as lipid 
(factor 1), centripetal fat with blood pressure (factor 3), and 
ACE gene along with blood pressure (factor 3). The ﬁ  rst 
2 factors, that is, lipids, centripetal fat and blood pressure 
cumulatively explained ~47% of the total variance of 
the MS in the study population. Except diastolic blood 
pressure, no overlapping of variables on more than 1 factor 
indicated that more than 1 variable is responsible for the 
ultimate phenotype of the MS. The present factor analysis 
conﬁ  rmed the general ﬁ  ndings from other factor analyses 
of the MS on different ethnic groups that had 3–4 factors 
identiﬁ  ed [Table 5].
The major limitation of this study is that it was performed 
on a relatively small sample size, and therefore is not 
representative of the Asian Indian population. Owing 
to considerable ethnic and cultural heterogeneity in the 
Asian Indian population, it is necessary to study other 
ethnic groups to see if the trends observed here also 
exist among them. However, it is noteworthy that results 
from different factor analysis are limited by differences in 
the ethnic group, sex, and age composition of the study 
samples, in the number of risk variables included, sample 
size, and cutoff points of loadings set by the investigators.[7] 
At the same time, to the best of our knowledge, no PCFA 
of MS has been undertaken so far, incorporating data on 
the angiotensin gene and the apolipoproteinE gene, along 
with the other confounding factors related to the MS in 
this part of the world. As Indian Diaspora offers a unique 
opportunity to study the “gene–environment” interaction 
involved in the etiology of CHD, further comparative 
studies between Indians living in India and Indians settled 
elsewhere could yield valuable information on the reasons 
behind the ethnic susceptibility to CHD among Indians.[7]
This model suggests that the clustering of the variables 
in MS is a result of multiple factors, including genetic 
polymorphisms with centripetal fat, lipids, and blood 
pressure playing key roles. Moreover, all the loaded risk 
variables, apart from the genetic polymorphism, are 
modifiable in nature. Therefore, it seems reasonable 
to argue that early prevention and proper intervention 
strategies to promote a healthy lifestyle could reduce the 
burden of MS in this part of the world.
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